InfuSystem EV/EBIT INFU

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2012.

Today, Oct 23, 2026: 22.4×
10-year median: 51.8×
Against its 10-year history: 23rd; percentile: 0 is its lowest day, 100 its highest
10-year range: 12.8× to 307×
Peer median: 14.6×

InfuSystem's EV/EBIT is 22.4× as of Oct 23, 2026.

That is below its ten-year median of 51.8×, lower than on 77% of days in the last ten years.

Over that time it ranged from 12.8× in Nov 2016 to 307× in Mar 2019.

The median for 10 medical instruments and supplies stocks of a similar size is 14.6×.

EV/EBIT over time

median 51.8×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	22.4×	14.5×	22.4×
2025	18.7×	16.7×	36.6×
2024	36.3×	36.3×	57.9×
2023	61.0×	51.2×	87.5×
2022	73.7×	54.1×	158×
2021	132×	38.5×	138×
2020	45.4×	34.4×	110×
2019	84.3×	79.1×	307×
2018	148×	148×	160×
2017	41.2×	19.1×	52.2×
2016	21.4×	12.7×	21.4×
2015	13.5×	9.0×	13.5×
2014	10.5×	9.6×	18.5×
2013	14.8×	12.6×	42.3×
2012	37.5×	30.2×	47.2×

Against its peers

Companies in Medical - Instruments & Supplies nearest InfuSystem's size, closest first, today.

Company	EV/EBIT
INFUInfuSystem	22.4×
UTMDUtah Medical Products	6.0×
EMBCEmbecta	6.7×
PDEXPro DEX	16.0×
TCMDTactile Systems Technology	13.3×
MDXGMimedx	51.6×
MOVMovado	11.8×
KEQUKewaunee Scientific	7.2×
IRMDIradimed	37.7×
STAAStaar Surgical	57.7×
BVSBioventus	26.2×
Peer median	14.6×

Where InfuSystem ranks

#25of 46Medical instruments and supplies stocks with the lowest EV/EBIT

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on InfuSystem

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.